Published in Cardiovascular Device Liability Week, November 6th, 2005
According to scientists writing in the Journal of Clinical Investigation, "The abnormal accumulation of amyloid beta-peptide (A beta) in the form of senile (or amyloid) plaques is one of the main characteristics of Alzheimer disease (AD). Both cholesterol and Cu2+ have been implicated in AD pathogenesis and plaque formation."
L. Puglielli and colleagues of the Harvard Medical School wrote, "A beta binds Cu2+ with very high affinity, forming a redox-active complex that catalyzes H2 O2 production from O2 and cholesterol....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.